ANIMALCARE GROUP PLC

AGM Information • Jun 10, 2025

National Storage Mechanism | Additional information

RNS Number : 2668M

Animalcare Group PLC

10 June 2025

Animalcare Group plc

(''Animalcare'', "the Company" or "the Group")

Result of 2025 AGM

10 June 2025. Animalcare Group plc confirms that all the resolutions put to the Annual General Meeting ("AGM") today were duly passed. All resolutions were decided on a poll. Resolutions 1 to 12 were passed as ordinary resolutions and resolutions 13 to 15 were passed as special resolutions. The voting results are given below.

No.	Resolution	Votes FOR (including discretionary)	%	Votes AGAINST	%	% of ISC Voted	Votes WITHHELD
1	To receive the audited annual accounts of the Company for the year ended 31 December 2024 together with the directors' report and the auditors' report on those annual accounts.	53,220,613	99.99	3,770	0.01	77.15	0
2	To declare a final dividend for the year ended 31 December 2024 of 3.0 pence per ordinary share.	53,224,137	99.99	246	0.01	77.15	0
3	To re-elect Mr C Brewster as a Director.	52,708,839	99.95	24,176	0.05	76.44	491,368
4	To re-elect Mr M Coucke as a Director.	53,186,483	99.95	24,176	0.05	77.13	13,724
5	To re-elect Mr D Hutchens as a Director.	48,896,136	91.88	4,318,794	8.12	77.14	9,453
6	To re-elect Ms S Metayer as a Director.	53,214,680	99.99	250	0.01	77.14	9,453
7	To re-elect Mr E Torr as a Director.	53,211,156	99.99	3,774	0.01	77.14	9,453
8	To re-elect Ms J Winter as a Director	53,190,754	99.95	24,176	0.05	77.14	9,453
9	To approve the Directors' Remuneration Report as set out in the Annual Report and Accounts 2024.	52,729,822	99.09	482,161	0.91	77.13	12,400
10	To approve the re-appointment of Grant Thornton UK LLP as auditors of the Company.	53,220,613	99.99	3,770	0.01	77.15	0
11	To authorise the Audit and Risk Committee to determine the remuneration of the auditors.	53,211,160	99.99	3,770	0.01	77.14	9,453
12	To authorise the Directors to allot shares.	48,971,758	92.01	4,250,425	7.99	77.15	2,200
13	To authorise the Directors to disapply statutory pre-emption rights in respect of the Company's issued share capital.	48,445,437	91.06	4,754,246	8.94	77.11	24,700
14	To authorise the Directors to disapply pre-emption rights for purposes of acquisitions or capital investments.	48,467,937	91.07	4,754,246	8.93	77.15	2,200
15	To authorise the Company to purchase its own shares.	51,794,306	99.99	3,946	0.01	75.08	1,426,131

Notes:

1.  Any proxy arrangement which gave discretion to the Chairman has been included in the "For" totals.

2.  A "Vote withheld" is not a vote in law and is not counted in the calculation of the percentage of shares voted "For" or "Against" any resolution.

3.  The number of shares in issue at 9.30am on 6 June 2025 was 68,989,072 ("ISC"). Holders of ordinary shares are entitled to one vote per share. No shares are held in treasury.

Animalcare Group Plc Jennifer Winter, Chief Executive Officer Chris Brewster, Chief Financial Officer Media/investor relations	+44 (0)1904 487 687 communications@animalcaregroup.com
Stifel (Nominated Advisor & Joint Broker) Ben Maddison Nicholas Harland Francis North	+44 (0)20 7710 7600
Panmure Liberum (Joint Broker) Corporate Finance Freddy Crossley/Emma Earl Corporate Banking Rupert Dearden Alma Strategic Communications Caroline Forde Kinvara Verdon Rose Docherty	+44 (0)20 7886 2500 +44 (0)20 3405 0205 animalcare@almastrategic.com

For more information, please visit www.animalcaregroup.com or contact:

About Animalcare

Animalcare Group plc is a UK AIM-listed international veterinary sales and marketing organisation. Animalcare operates in seven European countries as well as Australia and New Zealand and exports to approximately 40 countries worldwide. The Group is focused on bringing new and innovative products to market through its own development pipeline, partnerships and via acquisition.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGGPUWWQUPAGAU